Epstein-Barr Virus Nuclear Antigen (EBNA) Antibody (IgG)
Test Code
8564
86664
Clinical Significance
Epstein-Barr Virus Nuclear Antigen (EBNA) Antibody (IgG) - Primary infection by EBV causes infectious mononucleosis, usually a self-limiting disease in children and young adults. Infection with EBV can cause lymphoproliferative disorders including tumors. EBNA IgG typically appears during convalescence (3-4 months after clinical presentation) and remains detectable for life. VCA-IgM positivity in the absence of EBNA IgG suggests recent, active infection.
Test Resources
None found for this test
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
Methodology
Immunoassay (IA)
Reference Range(s)
| U/mL | Interpretation |
| <18.00 | Negative |
| 18.00-21.99 | Equivocal |
| >21.99 | Positive |
Alternative Name(s)
EBV Nuclear Antigen Antibody,EBV Past Infection,EBV NA
Preferred Specimen(s)
1 mL serum
Minimum Volume
0.5 mL
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 4 days
- Refrigerated: 7 days
- Frozen: 30 days
Setup Schedule
1 mL serum
0.5 mL
Transport tube
Room temperature
Room temperature: 4 days
Refrigerated: 7 days
Frozen: 30 days
Refrigerated: 7 days
Frozen: 30 days